The global artificial intelligence (AI) in drug discovery market size is expected to reach USD 4.05 billion by 2028 according to a new study. The report “Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Others); By Application; By Regions; Segment Forecast, 2021 - 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Based on therapeutic areas, the global artificial intelligence (AI) in drug discovery market is segmented into oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious diseases, and others. In 2020, the oncology segment accounted for the largest revenue share. Artificial intelligence plays an important role in the pre-diagnosis of cancer. Cancer treatments vary from person to person and personalized medicine has played an important role.
Artificial intelligence (AI) platforms are designed to ascertain genetic mutations, helping oncologists in designing effective treatment plans. In this line, a Switzerland-based company, Sophia Genetics developed an AI platform that helps to identify tumors by detecting genetic variations and devising personalized cancer treatment plans.
However, the infectious disease segment of artificial intelligence (AI) in drug discovery industry is projected to witness a lucrative growth rate over the study period. The increasing adoption of artificial intelligence (AI) platforms in infectious diseases to identify key infection patterns. A positive scenario for the segment is also illustrated by key partnerships and collaborations in the market for artificial intelligence (AI) in drug discovery.
For instance, artificial intelligence (AI)-based drug discovery company, Existencia, entered into an agreement with Scripps Research to identify COVID-19 antiviral therapies. On the same ground, Google’s Deepmind company also working on the artificial intelligence (AI) platform AlphaFold. The product is designed to provide information on several proteins involved in the diagnosis of SARS and COVID-19.
Market participants such as IBM Watson, Alphabet (DeepMind), Exscientia, GNS Healthcare, Insitro, BioSymetrics, Euretos, Berg Health, Benevolent AI, Atomwise, and Cyclica. are some of the key players operating in the global market. The companies in the artificial intelligence (AI) industry are involved in collaborations and partnerships with artificial intelligence (AI) platform providers to revolutionize medical treatment.
In this direction, in January 2021, the US-based provider of biomarkers-based therapy, Nucleai signed a collaboration agreement with Debiopharm, pharma company pioneering in drug development. According to the agreement the latter will use Nucleai’s artificial intelligence (AI) platform for its pipeline oncology drug candidates.
The publisher segmented the artificial intelligence in drug discovery market report on the basis of application, therapeutic area, and region:
Artificial Intelligence in Drug Discovery, Application Outlook
Based on therapeutic areas, the global artificial intelligence (AI) in drug discovery market is segmented into oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious diseases, and others. In 2020, the oncology segment accounted for the largest revenue share. Artificial intelligence plays an important role in the pre-diagnosis of cancer. Cancer treatments vary from person to person and personalized medicine has played an important role.
Artificial intelligence (AI) platforms are designed to ascertain genetic mutations, helping oncologists in designing effective treatment plans. In this line, a Switzerland-based company, Sophia Genetics developed an AI platform that helps to identify tumors by detecting genetic variations and devising personalized cancer treatment plans.
However, the infectious disease segment of artificial intelligence (AI) in drug discovery industry is projected to witness a lucrative growth rate over the study period. The increasing adoption of artificial intelligence (AI) platforms in infectious diseases to identify key infection patterns. A positive scenario for the segment is also illustrated by key partnerships and collaborations in the market for artificial intelligence (AI) in drug discovery.
For instance, artificial intelligence (AI)-based drug discovery company, Existencia, entered into an agreement with Scripps Research to identify COVID-19 antiviral therapies. On the same ground, Google’s Deepmind company also working on the artificial intelligence (AI) platform AlphaFold. The product is designed to provide information on several proteins involved in the diagnosis of SARS and COVID-19.
Market participants such as IBM Watson, Alphabet (DeepMind), Exscientia, GNS Healthcare, Insitro, BioSymetrics, Euretos, Berg Health, Benevolent AI, Atomwise, and Cyclica. are some of the key players operating in the global market. The companies in the artificial intelligence (AI) industry are involved in collaborations and partnerships with artificial intelligence (AI) platform providers to revolutionize medical treatment.
In this direction, in January 2021, the US-based provider of biomarkers-based therapy, Nucleai signed a collaboration agreement with Debiopharm, pharma company pioneering in drug development. According to the agreement the latter will use Nucleai’s artificial intelligence (AI) platform for its pipeline oncology drug candidates.
The publisher segmented the artificial intelligence in drug discovery market report on the basis of application, therapeutic area, and region:
Artificial Intelligence in Drug Discovery, Application Outlook
- Drug optimization and repurposing
- Preclinical testing
- Others
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- North America
- US
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Spain
- Netherlands
- Austria
- Asia Pacific
- China
- India
- Japan
- Malaysia
- Australia
- Indonesia
- Central & South America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Note: Product cover images may vary from those shown
1. Introduction
1.1. Report Description
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.2. Data Sources
4. Artificial Intelligence in Drug Discovery Market Insights
4.1. Artificial Intelligence in Drug Discovery – Industry snapshot
4.2. Artificial Intelligence in Drug Discovery Market Dynamics
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Artificial Intelligence in Drug Discovery Market Industry trends
4.6. COVID-19 Impact Analysis
5. Artificial Intelligence in Drug Discovery Market Assessment by Application
5.1. Key Findings
5.2. Introduction
5.3. Drug optimization and repurposing
5.4. Preclinical testing
5.5. Others
6. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area
6.1. Key Findings
6.2. Introduction
6.3. Oncology
6.4. Neurodegenerative Diseases
6.5. Cardiovascular Disease
6.6. Metabolic Diseases
6.7. Infectious Disease
6.8. Others
7. Artificial Intelligence in Drug Discovery Market Assessment by Geography
7.1. Key findings
7.2. Introduction
7.3. Artificial Intelligence in Drug Discovery Market – North America
7.4. Artificial Intelligence in Drug Discovery Market – Europe
7.5. Artificial Intelligence in Drug Discovery Market – Asia-Pacific
7.6. Artificial Intelligence in Drug Discovery Market – Middle East & Africa
7.7. Artificial Intelligence in Drug Discovery Market – Latin America
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. IBM Watson
9.2. Exscientia
9.3. GNS Healthcare
9.4. Alphabet (DeepMind)
9.5. Benevolent AI
9.6. BioSymetrics
9.7. Euretos
9.8. Berg Health
9.9. Atomwise
9.10. Cyclica
List of Tables
Table 1 Global Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 2 Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 3 Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2016 – 2028 (USD Million)
Table 4 North America: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 5 North America: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 6 U.S.: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 7 U.S.: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 8 Canada: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 9 Canada: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 10 Europe: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 11 Europe: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 12 UK: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 13 UK: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 14 France: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 15 France: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 16 Germany: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 17 Germany: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 18 Italy: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 19 Italy: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 20 Spain: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 21 Spain: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 22 Netherlands: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 23 Netherlands: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 24 Austria: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 25 Austria: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 26 Asia Pacific: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 27 Asia Pacific: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 28 China: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 29 China: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 30 India: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 31 India: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 32 Malaysia: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 33 Malaysia: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 34 Japan: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 35 Japan: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 36 Indonesia: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 37 Indonesia: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 38 South Korea: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 39 South Korea: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 40 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 41 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 42 Saudi Arabia: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 43 Saudi Arabia: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 44 UAE: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 45 UAE: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 46 Israel: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 47 Israel: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 48 South Africa: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 49 South Africa: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 50 Latin America: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 51 Latin America: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 52 Mexico: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 53 Mexico: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 54 Brazil: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 55 Brazil: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 56 Argentina: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 57 Argentina: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
List of Figures
Figure 1 Market Highlights (2020, Revenue)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top Down & Bottom Up Approach
Figure 4 Market by Geography
Figure 5 Porter’s Five Forces
Figure 6 Market by Application
Figure 7 Global Artificial Intelligence in Drug Discovery Market, By Application, 2020 & 2028 (USD Million)
Figure 8 Market by Therapeutic Area
Figure 9 Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2020 & 2028 (USD Million)
Figure 10 Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2016 – 2028 (USD Million)
Figure 11 Strategic Analysis – Artificial Intelligence in Drug Discovery Market
1.1. Report Description
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.2. Data Sources
4. Artificial Intelligence in Drug Discovery Market Insights
4.1. Artificial Intelligence in Drug Discovery – Industry snapshot
4.2. Artificial Intelligence in Drug Discovery Market Dynamics
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Artificial Intelligence in Drug Discovery Market Industry trends
4.6. COVID-19 Impact Analysis
5. Artificial Intelligence in Drug Discovery Market Assessment by Application
5.1. Key Findings
5.2. Introduction
5.3. Drug optimization and repurposing
5.4. Preclinical testing
5.5. Others
6. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area
6.1. Key Findings
6.2. Introduction
6.3. Oncology
6.4. Neurodegenerative Diseases
6.5. Cardiovascular Disease
6.6. Metabolic Diseases
6.7. Infectious Disease
6.8. Others
7. Artificial Intelligence in Drug Discovery Market Assessment by Geography
7.1. Key findings
7.2. Introduction
7.3. Artificial Intelligence in Drug Discovery Market – North America
7.4. Artificial Intelligence in Drug Discovery Market – Europe
7.5. Artificial Intelligence in Drug Discovery Market – Asia-Pacific
7.6. Artificial Intelligence in Drug Discovery Market – Middle East & Africa
7.7. Artificial Intelligence in Drug Discovery Market – Latin America
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. IBM Watson
9.2. Exscientia
9.3. GNS Healthcare
9.4. Alphabet (DeepMind)
9.5. Benevolent AI
9.6. BioSymetrics
9.7. Euretos
9.8. Berg Health
9.9. Atomwise
9.10. Cyclica
List of Tables
Table 1 Global Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 2 Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 3 Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2016 – 2028 (USD Million)
Table 4 North America: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 5 North America: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 6 U.S.: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 7 U.S.: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 8 Canada: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 9 Canada: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 10 Europe: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 11 Europe: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 12 UK: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 13 UK: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 14 France: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 15 France: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 16 Germany: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 17 Germany: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 18 Italy: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 19 Italy: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 20 Spain: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 21 Spain: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 22 Netherlands: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 23 Netherlands: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 24 Austria: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 25 Austria: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 26 Asia Pacific: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 27 Asia Pacific: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 28 China: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 29 China: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 30 India: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 31 India: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 32 Malaysia: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 33 Malaysia: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 34 Japan: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 35 Japan: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 36 Indonesia: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 37 Indonesia: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 38 South Korea: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 39 South Korea: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 40 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 41 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 42 Saudi Arabia: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 43 Saudi Arabia: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 44 UAE: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 45 UAE: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 46 Israel: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 47 Israel: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 48 South Africa: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 49 South Africa: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 50 Latin America: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 51 Latin America: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 52 Mexico: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 53 Mexico: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 54 Brazil: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 55 Brazil: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
Table 56 Argentina: Artificial Intelligence in Drug Discovery Market, By Application, 2016 – 2028 (USD Million)
Table 57 Argentina: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 – 2028 (USD Million)
List of Figures
Figure 1 Market Highlights (2020, Revenue)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top Down & Bottom Up Approach
Figure 4 Market by Geography
Figure 5 Porter’s Five Forces
Figure 6 Market by Application
Figure 7 Global Artificial Intelligence in Drug Discovery Market, By Application, 2020 & 2028 (USD Million)
Figure 8 Market by Therapeutic Area
Figure 9 Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2020 & 2028 (USD Million)
Figure 10 Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2016 – 2028 (USD Million)
Figure 11 Strategic Analysis – Artificial Intelligence in Drug Discovery Market
Note: Product cover images may vary from those shown
IBM Watson, Alphabet (DeepMind), Exscientia, GNS Healthcare, Insitro, BioSymetrics, Euretos, Berg Health, Benevolent AI, Atomwise, and Cyclica.
Note: Product cover images may vary from those shown
